The landscape of tyrosine kinase inhibitors in sarcomas: looking beyond pazopanib

Abstract excerpt

Introduction: Tyrosine kinases are key mediators of intracellular signaling cascades and aberrations in these proteins have been implicated in driving oncogenesis through the dysregulation of fundamental cellular processes including proliferation, migration, and apoptosis. As such, targeting these proteins with small molecule tyrosine kinase inhibitors (TKI) has led to significant advances in the treatment of a...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to CAR-T cell therapy research
• Share to Sarcoma Diagnosis and Treatment
• Share to Vascular Tumors and Angiosarcomas